BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33400401)

  • 1. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer.
    Iqbal MA; Siddiqui S; Ur Rehman A; Siddiqui FA; Singh P; Kumar B; Saluja D
    Mol Oncol; 2021 May; 15(5):1450-1465. PubMed ID: 33400401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.
    Cheng H; Hua L; Tang H; Bao Z; Xu X; Zhu H; Wang S; Jiapaer Z; Bhatia R; Dunn IF; Deng J; Wang D; Sun S; Luan S; Ji J; Xie Q; Yang X; Lei J; Li G; Wang X; Gong Y
    J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37791390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways underlying GATA6 regulating Trastuzumab resistance in Gastric Cancer cells based on untargeted metabolomics.
    Chang J; Wang Q; Bhetuwal A; Liu W
    Int J Med Sci; 2020; 17(18):3146-3164. PubMed ID: 33173435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance.
    Das C; Bhattacharya A; Adhikari S; Mondal A; Mondal P; Adhikary S; Roy S; Ramos K; Yadav KK; Tainer JA; Pandita TK
    Oncogene; 2024 Jun; 43(23):1727-1741. PubMed ID: 38719949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.
    Wang K; Zerdes I; Johansson HJ; Sarhan D; Sun Y; Kanellis DC; Sifakis EG; Mezheyeuski A; Liu X; Loman N; Hedenfalk I; Bergh J; Bartek J; Hatschek T; Lehtiö J; Matikas A; Foukakis T
    Nat Commun; 2024 May; 15(1):3837. PubMed ID: 38714665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiomic Metabolic Enrichment Network Analysis Reveals Metabolite-Protein Physical Interaction Subnetworks Altered in Cancer.
    Blum BC; Lin W; Lawton ML; Liu Q; Kwan J; Turcinovic I; Hekman R; Hu P; Emili A
    Mol Cell Proteomics; 2022 Jan; 21(1):100189. PubMed ID: 34933084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do cancer cells replenish their fuel supply?
    Alameddine AK; Conlin FT; Binnall BJ; Alameddine YA; Alameddine KO
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1003. PubMed ID: 32729259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells.
    Banerjee A; Arvinrad P; Darley M; Laversin SA; Parker R; Rose-Zerilli MJJ; Townsend PA; Cutress RI; Beers SA; Houghton FD; Birts CN; Blaydes JP
    Oncotarget; 2018 May; 9(33):23274-23288. PubMed ID: 29796188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox and metabolic reprogramming in breast cancer and cancer-associated adipose tissue.
    Zakic T; Pekovic-Vaughan V; Cvoro A; Korac A; Jankovic A; Korac B
    FEBS Lett; 2023 Dec; ():. PubMed ID: 38140817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: Regulation of circGOLPH3 and its binding protein CBX7 on the proliferation and apoptosis of prostate cancer cells.
    Biosci Rep; 2024 May; 44(5):. PubMed ID: 38757215
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma.
    Zhou J; Chen Z; Zou M; Wan R; Wu T; Luo Y; Wu G; Wang W; Liu T
    Front Oncol; 2021; 11():657595. PubMed ID: 34046352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review).
    Wang J; Yang B; Zhang X; Liu S; Pan X; Ma C; Ma S; Yu D; Wu W
    Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36734270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer.
    Li W; Chen H; Wang Z; Liu J; Lei X; Chen W
    J Gastrointest Oncol; 2022 Jun; 13(3):1058-1072. PubMed ID: 35837165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning.
    Ma Q; Chen L; Feng K; Guo W; Huang T; Cai YD
    Biochem Genet; 2024 Feb; ():. PubMed ID: 38383836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the role of aquaporin and chromobox family members as potential biomarkers in head and neck squamous cell carcinoma via integrative multiomics and in silico approach.
    Gurung R; Masood M; Singh P; Jha P; Sinha A; Ajmeriya S; Sharma M; Dohare R; Haque MM
    J Appl Genet; 2024 Feb; ():. PubMed ID: 38358594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade.
    Wang D; Yang Y; Yang L; Yang H
    Front Endocrinol (Lausanne); 2023; 14():1287101. PubMed ID: 38116321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2.
    Xing Y; Ba-Tu J; Dong C; Cao X; Li B; Jia X; Juan Y; Lv X; Zhang H; Qin N; Han W; Wang D; Qi X; Wang Y; Hao X; Zhang S; Du X; Wang H; Wang M
    Cell Death Dis; 2023 Nov; 14(11):782. PubMed ID: 38030604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBX7 is involved in the progression of cervical cancer through the ITGβ3/TGFβ1/AKT pathway.
    Tian P; Deng J; Ma C; Miershali A; Maimaitirexiati G; Yan Q; Liu Y; Maimaiti H; Li Y; Zhou C; Ren J; Ding L; Li R
    Oncol Lett; 2024 Jan; 27(1):14. PubMed ID: 38028179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic stratification of human breast tumors reveal subtypes of clinical and therapeutic relevance.
    Iqbal MA; Siddiqui S; Smith K; Singh P; Kumar B; Chouaib S; Chandrasekaran S
    iScience; 2023 Oct; 26(10):108059. PubMed ID: 37854701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of multi-omic regulation in breast cancer.
    Ochoa S; Hernández-Lemus E
    Front Oncol; 2023; 13():1148861. PubMed ID: 37564937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.